The role of the vagus nerve in depression

Neuroendocrinology Letters

Volumn 31, Issue 5, 2010, Pages 602-608

  Ondicova, Katarina ^a   Pecenak, Jan ^a   Mravec, Boris ^a,b  

^a Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^b INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

Author keywords

Antidepressant; Cytokines; Depression; Gastrointestinal tract; Hypothalamic pituitary adrenal axis; Inflammation; Monoaminergic neurotransmission; Neuroplasticity; Vagus nerve

Indexed keywords

C REACTIVE PROTEIN; MONOAMINE;

AFFERENT NERVE GROUP 1; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; EFFERENT NERVE; ELECTROSTIMULATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; ILLNESS BEHAVIOR; INFLAMMATION; NERVE CELL PLASTICITY; NEUROBIOLOGY; NEUROMODULATION; NEUROTRANSMISSION; PATHOGENESIS; REGULATORY MECHANISM; REVIEW; VAGUS NERVE; VAGUS NERVE STIMULATION; VAGUS TONE;

EID: 79851500282     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Akhondzadeh S, Jafari S, Raisi F, Nasehi AA, Ghoreishi A, Salehi B, et al. (2009). Clinical trial of adjunctive celecoxib treatment in patients with major depression: A double blind and placebo controlled trial. Depress Anxiety. 26: 607-611.
2. Asnis GM, De La Garza R, 2nd (2006). Interferon-induced depression in chronic hepatitis c: A review of its prevalence, risk factors, biology, and treatment approaches. J Clin Gastroenterol. 40: 322-335.
3. Baune B (2009). Conceptual challenges of a tentative model of stress-induced depression. PLoS One. 4: e4266.
4. Bluthe RM, Michaud B, Poli V, Dantzer R (2000). Role of il-6 in cytokine-induced sickness behavior: A study with il-6 deficient mice. Physiol Behav. 70: 367-373.
5. Brunello N, Alboni S, Capone G, Benatti C, Blom JM, Tascedda F, et al. (2006). Acetylsalicylic acid accelerates the antidepressant effect of fluoxetine in the chronic escape deficit model of depression. Int Clin Psychopharmacol. 21: 219-225. (Pubitemid 43740299)
6. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 301(5631): 386-389. (Pubitemid 36877077)
7. Chambers AS, Allen JJ (2002). Vagal tone as an indicator of treatment response in major depression. Psychophysiology. 39: 861-864.
8. Cunningham JT, Mifflin SW, Gould GG, Frazer A (2008). Induction of c-fos and deltafosb immunoreactivity in rat brain by vagal nerve stimulation. Neuropsychopharmacology. 33: 1884-1895. (Pubitemid 351832591)
9. Das UN (2007). Vagus nerve stimulation, depression, and inflammation. Neuropsychopharmacology. 32: 2053-2054.
10. De Herdt V, Puimege L, De Waele J, Raedt R, Wyckhuys T, El Tahry R, et al. (2009). Increased rat serum corticosterone suggests immunomodulation by stimulation of the vagal nerve. J Neuroimmunol. 212: 102-105.
11. De La Garza R, 2nd, Asnis GM, Fabrizio KR, Pedrosa E (2005). Acute diclofenac treatment attenuates lipopolysaccharide-induced alterations to basic reward behavior and hpa axis activation in rats. Psychopharmacology (Berl). 179: 356-365. (Pubitemid 40569041)
12. De La Garza R, 2nd, Fabrizio KR, Radoi GE, Vlad T, Asnis GM (2004). The non-steroidal anti-inflammatory drug diclofenac sodium attenuates lipopolysaccharide-induced alterations to reward behavior and corticosterone release. Behav Brain Res. 149: 77-85. (Pubitemid 38096369)
13. Ek M, Kurosawa M, Lundeberg T, Ericsson A (1998). Activation of vagal afferents after intravenous injection of interleukin-1beta: Role of endogenous prostaglandins. J Neurosci. 18: 9471-9479. (Pubitemid 28512476)
14. Follesa P, Biggio F, Gorini G, Caria S, Talani G, Dazzi L, et al. (2007). Vagus nerve stimulation increases norepinephrine concentration and the gene expression of bdnf and bfgf in the rat brain. Brain Res. 1179: 28-34. (Pubitemid 47633509)
15. Fredericks CA, Drabant EM, Edge MD, Tillie JM, Hallmayer J, Ramel W, et al. (2010). Healthy young women with serotonin transporter ss polymorphism show a pro-inflammatory bias under resting and stress conditions. Brain Behav Immun. 24: 350-357.
16. Fuchs E, Czeh B, KoIe MH, Michaelis T, Lucassen PJ (2004). Alterations of neuroplasticity in depression: The hippocampus and beyond. Eur Neuropsychopharmacol. 14 Suppl 5: S481-490.
17. Galea E, Heneka MT, Dello Russo C, Feinstein DL (2003). Intrinsic regulation of brain inflammatory responses. Cell Mol Neurobiol. 23: 625-635. (Pubitemid 37071489)
18. George MS, Aston-Jones G (2010). Noninvasive techniques for probing neurocircuitry and treating illness: Vagus nerve stimulation (vns), transcranial magnetic stimulation (tms) and transcranial direct current stimulation (tdcs). Neuropsychopharmacology. 35: 301-316.
19. George MS, Nahas Z, Borckardt JJ, Anderson B, Burns C, Kose S, et al. (2007). Vagus nerve stimulation for the treatment of depression and other neuropsychiatric disorders. Expert Rev Neurother. 7: 63-74. (Pubitemid 46115932)
20. Ghia JE, Blennerhassett P, Deng Y, Verdu EF, Khan WI, Collins SM (2009). Reactivation of inflammatory bowel disease in a mouse model of depression. Gastroenterology. 136: 2280-2288 e2281-2284.
21. Goehler LE, Lyte M, Gaykema RP (2007). Infection-induced viscerosensory signals from the gut enhance anxiety: Implications for psychoneuroimmunology. Brain Behav Immun. 21: 721-726. (Pubitemid 47002214)
22. Gold PW, Chrousos GP (2002). Organization of the stress system and its dysregulation in melancholic and atypical depression: High vs low crh/ne states. Mol Psychiatry. 7: 254-275. (Pubitemid 34280634)
23. Hansen MK, Jaishi P, Chen Z, Krueger JM (1998). Vagotomy blocks the induction of interleukin-1 beta (il-1 beta) mrna in the brain of rats in response to systemic il-1 beta. J Neurosci. 18: 2247-2253. (Pubitemid 28141429)
24. Huston JM, Ochani M, Rosas-Ballina M, Liao H, Ochani K, Pavlov VA, et al. (2006). Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med. 203: 1623-1628.
25. Konsman JP, Luheshi GN, Bluthe RM, Dantzer R (2000). The vagus nerve mediates behavioural depression, but not fever, in response to peripheral immune signals; a functional anatomical analysis. Eur J Neurosci. 12: 4434-4446. (Pubitemid 32037852)
26. Krishnan V, Nestler EJ (2008). The molecular neurobiology of depression. Nature. 455: 894-902.
27. Kurina LM, Goldacre MJ, Yeates D, Gill LE (2001). Depression and anxiety in people with inflammatory bowel disease. J Epidemiol Community Health. 55: 716-720. (Pubitemid 32881818)
28. Lang UE, Bajbouj M, Gallinat J, Hellweg R (2006). Brain-derived neurotrophic factor serum concentrations in depressive patients during vagus nerve stimulation and repetitive transcranial magnetic stimulation. Psychopharmacology (Berl). 187: 56-59. (Pubitemid 43876916)
29. Maes M (2008). The cytokine hypothesis of depression: Inflammation, oxidative & nitrosative stress (io&ns) and leaky gut as new targets for adjunctive treatments in depression. Neuro Endocrinol Lett. 29: 287-291.
30. Maes M, Yirmyia R, Noraberg J, Brene S, Hibbeln J, Perini G, et al. (2009). The inflammatory & neurodegenerative (i&nd) hypothesis of depression: Leads for future research and new drug developments in depression. Metab Brain Dis. 24: 27-53.
31. Maier SF, Goehler LE, Fleshner M, Watkins LR (1998). The role of the vagus nerve in cytokine-to-brain communication. Ann N Y Acad Sci. 840: 289-300. (Pubitemid 28302056)
32. Mann JJ (2005). The medical management of depression. N Engl J Med. 353: 1819-1834.
33. Manta S, Dong J, Debonnel G, Blier P (2009). Enhancement of the function of rat serotonin and norepinephrine neurons by sustained vagus nerve stimulation. J Psychiatry Neurosci. 34: 272-280.
34. Manta S, Dong J, Debonnel G, Blier P (2009). Optimization of vagus nerve stimulation parameters using the firing activity of serotonin neurons in the rat dorsal raphe. Eur Neuropsychopharmacol. 19: 250-255.
35. Mendlewicz J, Kriwin P, Oswald P, Souery D, Alboni S, Brunello N (2006). Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: A pilot open-label study. Int Clin Psychopharmacol. 21: 227-231. (Pubitemid 43740300)
36. Miller AH, Maletic V, Raison CL (2009). Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 65: 732-741.
37. Nemeroff CB, Mayberg HS, Krahl SE, McNamara J, Frazer A, Henry TR, et al. (2006). Vns therapy in treatment-resistant depression: Clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology. 31: 1345-1355.
38. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM (2002). Neurobiology of depression. Neuron. 34: 13-25. (Pubitemid 34270695)
39. Nishida A, Miyaoka T, Inagaki T, Horiguchi J (2009). New approaches to antidepressant drug design: Cytokine-regulated pathways. Curr Pharm Des. 15: 1683-1687.
40. O'Brien SM, Scott LV, Dinan TG (2004). Cytokines: Abnormalities in major depression and implications for pharmacological treatment. Hum Psychopharmacol. 19: 397-403. (Pubitemid 39172804)
41. Oke SL, Tracey KJ (2009). The inflammatory reflex and the role of complementary and alternative medical therapies. Ann N Y Acad Sci. 1172: 172-180.
42. O'Keane V, Dinan TG, Scott L, Corcoran C (2005). Changes in hypothalamic-pituitary-adrenal axis measures after vagus nerve stimulation therapy in chronic depression. Biol Psychiatry. 58: 963-968. (Pubitemid 41790706)
43. O'Sullivan JB, Ryan KM, Curtin NM, Harkin A, Connor TJ (2009). Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: Implications for depression and neurodegeneration. Int J Neuropsychopharmacol. 12: 687-699.
44. Pace TW (2010). New pieces for the stress-depression puzzle. Brain Behav Immun. 24: 348-349.
45. Pariante CM, Lightman SL (2008). The hpa axis in major depression: Classical theories and new developments. Trends Neurosci. 31: 464-468.
46. Perry VH (2004). The influence of systemic inflammation on inflammation in the brain: Implications for chronic neurodegenerative disease. Brain Behav Immun. 18: 407-413.
47. Racagni G, Popoli M (2008). Cellular and molecular mechanisms in the long-term action of antidepressants. Dialogues Clin Neurosci. 10: 385-400.
48. Ressler KJ, Mayberg HS (2007). Targeting abnormal neural circuits in mood and anxiety disorders: From the laboratory to the clinic. Nat Neurosci. 10: 1116-1124. (Pubitemid 47339944)
49. Revesz D, Tjernstrom M, Ben-Menachem E, Thorlin T (2008). Effects of vagus nerve stimulation on rat hippocampal progenitor proliferation. Exp Neurol. 214: 259-265.
50. Rohleder N (2009). Adding another level of complexity to the depression-inflammation link: What mediates the mediator? Brain Behav Immun. 23: 411-412.
51. Roosevelt RW, Smith DC, Clough RW, Jensen RA, Browning RA (2006). Increased extracellular concentrations of norepinephrine in cortex and hippocampus following vagus nerve stimulation in the rat. Brain Res. 1119: 124-132. (Pubitemid 44647233)
52. Rosas-Ballina M, Tracey KJ (2009). Cholinergic control of inflammation. J Intern Med. 265: 663-679.
53. Rosas-Ballina M, Tracey KJ (2009). The neurology of the immune system: Neural reflexes regulate immunity. Neuron. 64: 28-32.
54. Roumestan C, Michel A, Bichon F, Portet K, Detoc M, Henriquet C, et al. (2007). Anti-inflammatory properties of desipramine and fluoxetine. Respir Res. 8: 35.
55. Schule C (2007). Neuroendocrinological mechanisms of actions of antidepressant drugs. J Neuroendocrinol. 19: 213-226.
56. Simen BB, Duman CH, Simen AA, Duman RS (2006).Tnfalpha signaling in depression and anxiety: Behavioral consequences of individual receptor targeting. Biol Psychiatry. 59: 775 785.
57. Steptoe A, Hamer M, Chida Y (2007). The effects of acute psychological stress on circulating inflammatory factors in humans: A review and meta-analysis. Brain Behav Immun. 21: 901-912. (Pubitemid 47285684)
58. Su S, Zhao J, Bremner JD, Miller AH, Tang W, Bouzyk M, et al. (2009). Serotonin transporter gene, depressive symptoms, and interleukin-6. Circ Cardiovasc Genet. 2: 614-620.
59. Tracey KJ (2002). The inflammatory reflex. Nature. 420: 853-859.
60. Van Der Zanden EP, Boeckxstaens GE, de Jonge WJ (2009). The vagus nerve as a modulator of intestinal inflammation. Neurogastroenterol Motil. 21: 6-17.
61. Woods JA, Vieira VJ, Keylock KT (2006). Exercise, inflammation, and innate immunity. Neurol Clin. 24: 585-599.
62. Yang AC, Chen TJ, Tsai SJ, Hong CJ, Kuo CH, Yang CH, et al. (2010). Bdnf val66met polymorphism alters sympathovagal balance in healthy subjects. Am J Med Genet B Neuropsychiatr Genet.
63. Zec N, Kinney HC (2003). Anatomic relationships of the human nucleus of the solitary tract in the medulla oblongata: A dii labeling study. Auton Neurosci. 105: 131-144. (Pubitemid 36683065)